The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 37, No. 6, pp. 899-904. DOI 10.1345/aph.1C163
© 2003 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pharand, C.
Right arrow Articles by Pearson, G. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pharand, C.
Right arrow Articles by Pearson, G. J

Use of OTC and Herbal Products in Patients with Cardiovascular Disease

Chantal Pharand, PharmD BCPS

Associate Professor, Faculty of Pharmacy, Université de Montréal and Hôpital du Sacré-Coeur de Montréal, Montréal, Québec, Canada

Margaret L Ackman, PharmD

Clinical Coordinator, Cardiac Sciences, Regional Pharmacy Services, Capital Health; Clinical Associate Professor, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada

Cynthia A Jackevicius, MSc FCSHP

Practice Leader, Pharmacy Department and Associate, Women's Health Program, University Health Network; Assistant Professor, Faculty of Medicine, University of Toronto; Adjunct Scientist, Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada

Fran L Paradiso-Hardy, MSc FCSHP

Clinical Coordinator, Cardiovascular Diseases, Sunnybrook & Women's College Health Sciences Centre, North York, Ontario; Assistant Professor, Faculty of Pharmacy, University of Toronto

Glen J Pearson, PharmD FCSHP the Canadian Cardiovascular Pharmacists Networka

Assistant Professor of Medicine, Faculty of Medicine & Dentistry; Co-Director, Cardiac Transplant Clinic; Deputy Medical Director & Director of Research, Cardiovascular Risk Reduction Clinic, Division of Cardiology, University of Alberta

Reprints: Chantal Pharand PharmD BCPS, Centre de Recherche, Hôpital du Sacré-Coeur de Montréal, 5400, boul. Gouin ouest, Montréal, Québec, H4J 1C5, Canada, FAX 514/338-2694, E-mail pharandc{at}crhsc.umontreal.ca

BACKGROUND: The use of nonprescription and herbal products by the public is rising, resulting in an increased potential for adverse reactions or drug interactions in cardiac patients.

OBJECTIVE: To describe the utilization patterns for nonprescription medications and herbal products in patients with cardiovascular disease across Canada.

METHODS: Patients admitted to 8 teaching hospitals during the winter of 1998/1999 were interviewed by a pharmacist using a structured survey instrument.

RESULTS: Interviews were conducted with 306 patients (mean age 66 y; 60% men). The majority (74%) had coronary artery disease; however, hypertension, congestive heart failure, and arrhythmias were also common. The most common product categories used were pain relievers (51%), single-entity vitamin/mineral (38%), multivitamin/mineral (23%), antacids (21%), laxatives (17%), and herbals (17%). As compared with western (28%) and central Canada (26%), fewer patients in the Atlantic region (11%) reported daily use of multivitamin/mineral products. Overall, the usage of specific single-entity vitamin/mineral products was most commonly vitamin E (24%), vitamin C (16%), calcium (9%), and B vitamins (8%). Central Canada reported the highest rates (25%) of daily or weekly use of herbal products. The most common herbal products used were garlic (13%), cayenne pepper (2%), and ginseng (2%). More than half of the patients consulted with their pharmacist at least occasionally regarding the use of these products.

CONCLUSIONS: Canadian patients with cardiovascular disease commonly report the use of herbal products and vitamins. Allied health professionals need to be aware of the widespread use of these products and their potential for adverse reactions and drug interactions.

Key Words: cardiovascular diseases, herbal medicines, nonprescription drugs, patient care




This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
P. G Clay, A. G Glaros, and K. A Clauson
Perceived Efficacy, Indications, and Information Sources for Medically Indigent Patients and Their Healthcare Providers Regarding Dietary Supplements
Ann. Pharmacother., March 1, 2006; 40(3): 427 - 432.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
C. Buettner, G. Y Yeh, R. S Phillips, M. A Mittleman, and T. J Kaptchuk
Systematic Review of the Effects of Ginseng on Cardiovascular Risk Factors
Ann. Pharmacother., January 1, 2006; 40(1): 83 - 95.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
K N Woodward
The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products
Human and Experimental Toxicology, May 1, 2005; 24(5): 219 - 233.
[Abstract] [PDF]


Home page
The Annals of PharmacotherapyHome page
C. L Richard and T. M Jurgens
Effects of Natural Health Products on Blood Pressure
Ann. Pharmacother., April 1, 2005; 39(4): 712 - 720.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2003 by Harvey Whitney Books Company.